Multicenter 	Multicenter 	 NNP	B-NP
,  	,  	 ,	O
randomized 	randomized 	 NN	O
,  	,  	 ,	O
parallel-group  	parallel-group  	 JJ	B-NP
study  	study  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
safety  	safety  	 NN	O
and  	and  	 CC	O
effectiveness  	effectiveness  	 NN	O
of  	of  	 IN	O
onabotulinumtoxinA  	onabotulinumtoxinA  	 JJ	O
and  	and  	 CC	O
hyaluronic  	hyaluronic  	 FW	B-NP
acid  	acid  	 FW	I-NP
dermal  	dermal  	 FW	I-NP
fillers  	fillers  	 FW	I-NP
( 	( 	 -LRB-	O
24-mg 	24-mg 	 FW	O
/ 	/ 	 FW	O
ml  	ml  	 FW	O
smooth 	smooth 	 FW	O
,  	,  	 ,	O
cohesive  	cohesive  	 JJ	B-NP
gel 	gel 	 NN	I-NP
)  	)  	 -RRB-	O
alone  	alone  	 RB	O
and  	and  	 CC	O
in  	in  	 IN	O
combination  	combination  	 NN	O
for  	for  	 IN	O
lower  	lower  	 JJR	O
facial  	facial  	 JJ	B-NP
rejuvenation  	rejuvenation  	 NN	I-NP
Combination  	Combination  	 NNP	I-NP
treatment  	treatment  	 NN	I-NP
with  	with  	 IN	O
toxins  	toxins  	 NN	O
and  	and  	 CC	O
fillers  	fillers  	 NN	B-NP
is  	is  	 VBZ	O
the  	the  	 DT	O
standard  	standard  	 JJ	O
regimen  	regimen  	 NN	O
in  	in  	 IN	O
facial  	facial  	 JJ	B-NP
rejuvenation 	rejuvenation 	 NN	I-NP
.  	.  	 .	O
Systematic  	Systematic  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
of  	of  	 IN	I-NP
botulinum  	botulinum  	 JJ	I-NP
toxin  	toxin  	 NN	I-NP
alone  	alone  	 RB	O
and  	and  	 CC	O
in  	in  	 IN	O
combination  	combination  	 NN	O
with  	with  	 IN	O
hyaluronic  	hyaluronic  	 JJ	B-NP
acid  	acid  	 NN	I-NP
( 	( 	 -LRB-	O
HA 	HA 	 NNP	B-NP
)  	)  	 -RRB-	O
have  	have  	 VBP	O
not 	not 	 RB	O
,  	,  	 ,	O
however 	however 	 RB	O
,  	,  	 ,	O
been  	been  	 VBN	O
conducted  	conducted  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
lower  	lower  	 JJR	O
face 	face 	 NN	O
.  	.  	 .	O
To  	To  	 TO	O
evaluate  	evaluate  	 VB	O
safety  	safety  	 NN	O
and  	and  	 CC	O
effectiveness  	effectiveness  	 NN	O
and  	and  	 CC	O
compare  	compare  	 VB	O
combination  	combination  	 NN	B-NP
treatment  	treatment  	 NN	I-NP
with  	with  	 IN	O
onabotulinumtoxinA  	onabotulinumtoxinA  	 JJ	O
and  	and  	 CC	O
a  	a  	 DT	O
24-mg 	24-mg 	 CD	O
/ 	/ 	 CD	O
mL  	mL  	 JJ	O
smooth 	smooth 	 JJ	O
,  	,  	 ,	O
cohesive  	cohesive  	 FW	B-NP
HA  	HA  	 FW	I-NP
gel  	gel  	 FW	I-NP
filler  	filler  	 FW	I-NP
with  	with  	 IN	O
either  	either  	 DT	O
treatment  	treatment  	 NN	O
alone  	alone  	 RB	O
for  	for  	 IN	O
rejuvenation  	rejuvenation  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
perioral  	perioral  	 JJ	I-NP
area  	area  	 NN	I-NP
and  	and  	 CC	O
lower  	lower  	 JJR	O
face  	face  	 NN	O
in  	in  	 IN	O
female  	female  	 JJ	O
subjects 	subjects 	 NNS	B-NP
.  	.  	 .	O
Ninety  	Ninety  	 JJ	O
female  	female  	 JJ	O
participants  	participants  	 NNS	B-NP
aged  	aged  	 VBN	O
35  	35  	 CD	O
to  	to  	 TO	O
55  	55  	 CD	O
were  	were  	 VBD	O
randomized  	randomized  	 VBN	O
to  	to  	 TO	O
one  	one  	 CD	O
of  	of  	 IN	O
three  	three  	 CD	O
groups 	groups 	 NNS	O
:  	:  	 :	O
24-mg 	24-mg 	 FW	O
/ 	/ 	 FW	O
mL  	mL  	 FW	O
cohesive  	cohesive  	 FW	B-NP
gel  	gel  	 FW	I-NP
alone  	alone  	 FW	O
( 	( 	 -LRB-	O
n=30 	n=30 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
onabotulinumtoxinA  	onabotulinumtoxinA  	 JJ	O
alone  	alone  	 NNS	O
( 	( 	 -LRB-	O
n=30 	n=30 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
or  	or  	 CC	O
the  	the  	 DT	O
combination  	combination  	 NN	O
( 	( 	 -LRB-	O
n=30 	n=30 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Effectiveness  	Effectiveness  	 NN	B-NP
outcomes  	outcomes  	 NNS	I-NP
included  	included  	 VBD	I-NP
perioral 	perioral 	 CD	I-NP
,  	,  	 ,	O
lip  	lip  	 JJ	O
fullness 	fullness 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
oral  	oral  	 JJ	B-NP
commissure  	commissure  	 JJ	I-NP
assessments  	assessments  	 NNS	I-NP
and  	and  	 CC	O
scores  	scores  	 NNS	O
on  	on  	 IN	O
the  	the  	 DT	O
Cosmetic  	Cosmetic  	 NNP	B-NP
Improvement  	Improvement  	 NNP	I-NP
and  	and  	 CC	O
Global  	Global  	 NNP	B-NP
Aesthetic  	Aesthetic  	 NNP	I-NP
Improvement  	Improvement  	 NNP	I-NP
Scales 	Scales 	 NNP	I-NP
.  	.  	 .	O
Adverse  	Adverse  	 JJ	B-NP
events  	events  	 NNS	I-NP
were  	were  	 VBD	O
monitored  	monitored  	 VBN	O
throughout 	throughout 	 IN	O
.  	.  	 .	O
For  	For  	 IN	O
all  	all  	 DT	O
end  	end  	 NN	B-NP
points  	points  	 NNS	I-NP
and  	and  	 CC	O
most  	most  	 JJS	O
time  	time  	 NN	B-NP
points 	points 	 NNS	I-NP
,  	,  	 ,	O
subjects  	subjects  	 VBZ	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
onabotulinumtoxinA  	onabotulinumtoxinA  	 JJ	O
plus  	plus  	 CC	O
the  	the  	 DT	O
24-mg 	24-mg 	 CD	O
/ 	/ 	 CD	O
mL  	mL  	 JJ	O
cohesive  	cohesive  	 JJ	B-NP
gel  	gel  	 NN	I-NP
had  	had  	 VBD	O
greater  	greater  	 JJR	O
improvement  	improvement  	 NN	O
from  	from  	 IN	O
baseline  	baseline  	 NN	B-NP
than  	than  	 IN	O
subjects  	subjects  	 NNS	B-NP
treated  	treated  	 VBN	O
with  	with  	 IN	O
onabotulinumtoxinA  	onabotulinumtoxinA  	 JJ	O
or  	or  	 CC	O
the  	the  	 DT	O
24-mg 	24-mg 	 FW	O
/ 	/ 	 FW	O
mL  	mL  	 FW	O
cohesive  	cohesive  	 FW	B-NP
gel  	gel  	 FW	I-NP
filler  	filler  	 FW	I-NP
alone 	alone 	 FW	O
.  	.  	 .	O
Based  	Based  	 VBN	O
on  	on  	 IN	O
a  	a  	 DT	O
range  	range  	 NN	O
of  	of  	 IN	O
end  	end  	 NN	B-NP
points 	points 	 NNS	I-NP
,  	,  	 ,	O
onabotulinumtoxinA  	onabotulinumtoxinA  	 JJ	O
and  	and  	 CC	O
24-mg 	24-mg 	 FW	O
/ 	/ 	 FW	O
mL  	mL  	 FW	O
cohesive  	cohesive  	 FW	B-NP
HA  	HA  	 FW	I-NP
gel  	gel  	 FW	I-NP
treatments  	treatments  	 NNS	I-NP
are  	are  	 VBP	O
effective  	effective  	 JJ	O
and  	and  	 CC	O
safe  	safe  	 JJ	O
when  	when  	 WRB	O
either  	either  	 RB	O
alone  	alone  	 RB	O
or  	or  	 CC	O
in  	in  	 IN	O
combination  	combination  	 NN	O
to  	to  	 TO	O
rejuvenate  	rejuvenate  	 VB	O
the  	the  	 DT	O
lower  	lower  	 JJR	O
face 	face 	 NN	O
.  	.  	 .	O
Combination  	Combination  	 NN	B-NP
therapy  	therapy  	 NN	I-NP
is  	is  	 VBZ	O
superior  	superior  	 JJ	O
to  	to  	 TO	O
either  	either  	 DT	O
modality  	modality  	 NN	B-NP
used  	used  	 VBD	O
alone 	alone 	 RB	O
.  	.  	 .	O
